carmengabriela/iStock Editorial via Getty Images Pfizer (NYSE:PFE) is scheduled to announce Q4 earnings results on
georgeclerk Pfizer (NYSE:PFE) reported positive topline results from a Phase 3 study of its drug
mesh cube The European Medicine Agency’s Commitee for Medicinal Products for Human Use has issued
Nurix Therapeutics (NASDAQ:NRIX) will begin trials later this year for its experimental BTK degrader NX-5948
georgeclerk Activist investor Starboard Value is not pursuing a proxy battle for Pfizer (NYSE:PFE). The
georgeclerk Pfizer (NYSE:PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven
ismagilov Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced
2d illustrations and photos Takeda-backed Ascentage Pharma Group (AAPG) (OTCPK:ASPHF), which is developing treatments for
koto_feja Zai Lab (NASDAQ:ZLAB) announced Wednesday it would seek marketing approval for its cervical cancer
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) announced Tuesday it plans to sell roughly 700M ordinary